Related Experiment Videos
Parainfluenza virus infection in adult bone marrow transplant recipients
E Whimbey1, S E Vartivarian, R E Champlin
1Section of Infectious Diseases, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Abstract:
The clinical course of parainfluenza virus infection occurring in 8 of 265 (3%) adult bone marrow transplant recipients during 1991 was reviewed. Parainfluenza virus type 3 was isolated from all eight patients. The clinical course ranged from self-limited upper respiratory tract infections (2 patients) to severe lower respiratory tract disease (6 patients) associated with a 50% mortality. This study highlights the important role of community respiratory viruses such as parainfluenza virus in the etiology of pneumonia in immunocompromised adults.
Insights
Parainfluenza virus type 3 caused severe pneumonia in 50% of adult bone marrow transplant recipients. This highlights the risk of community respiratory viruses in immunocompromised patients.
Area of Science:
- Infectious Diseases
- Immunology
- Transplantation
Background:
- Bone marrow transplant recipients are highly susceptible to infections.
- Community respiratory viruses can cause severe illness in immunocompromised individuals.
Purpose of the Study:
- To review the clinical course of parainfluenza virus infection in adult bone marrow transplant recipients.
- To determine the impact of parainfluenza virus on this patient population.
Main Methods:
- Retrospective review of 265 adult bone marrow transplant recipients.
- Isolation and identification of parainfluenza virus from infected patients.
- Analysis of clinical presentation, disease severity, and outcomes.
Main Results:
- Parainfluenza virus infection occurred in 3% (8 of 265) of recipients.
- Parainfluenza virus type 3 was identified in all cases.
- Infections ranged from mild upper respiratory illness to severe lower respiratory disease.
- Severe disease was associated with a 50% mortality rate.
Conclusions:
- Parainfluenza virus is a significant pathogen in adult bone marrow transplant recipients.
- Immunocompromised hosts are at high risk for severe outcomes from community respiratory viruses.
- Early recognition and management are crucial for improving outcomes.